Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Guttman

Showing results (371-380 of 387) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
The Journal of Allergy and Clinical Immunology|January 15, 2019
Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions"Wendy F Davidson, Donald Y M Leung, Lisa A Beck, et al.
Allergy|February 6, 2021
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticumLianghua Bin, Claire Malley, Patricia Taylor, et al.
Allergy|June 30, 2025
The Evolution, Immunopathogenesis and Biomarkers of Type 2 Inflammation in Common Allergic DisordersYa-Dong Gao, Zi-Jun Wang, Ismail Ogulur, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual MeetingArianna J Zhang, Gretchen Ball, Melissa P Zundell, et al.
Allergy|December 18, 2025
Clinical and Molecular Effect of the Anti-IL-18 Antibody Aletekitug in Adults With Atopic DermatitisJoanne Ellis, Léa Fortunato, Hannah Wajdner, et al.
The Journal of Allergy and Clinical Immunology|January 7, 2024
Regulatory T-cell dysfunction and cutaneous exposure to Staphylococcus aureus underlie eczema in DOCK8 deficiencyHazel Wilkie, Mrinmoy Das, Tyler Pelovitz, et al.
The British Journal of Dermatology|September 9, 2024
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema CouncilCarter Haag, Andrew Alexis, Valeria Aoki, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Clinical and Translational Medicine|May 6, 2022
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trialAnne Weiss, Emilie Delavenne, Carina Matias, et al.
Pageof 39

Showing results (371-380 of 387) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology|August 20, 2018
Baseline IL-22 expression in patients with atopic dermatitis stratifies tissue responses to fezakinumabPatrick M Brunner, Ana B Pavel, Saakshi Khattri, et al.
The Journal of Allergy and Clinical Immunology|January 15, 2019
Report from the National Institute of Allergy and Infectious Diseases workshop on "Atopic dermatitis and the atopic march: Mechanisms and interventions"Wendy F Davidson, Donald Y M Leung, Lisa A Beck, et al.
Allergy|February 6, 2021
Whole genome sequencing identifies novel genetic mutations in patients with eczema herpeticumLianghua Bin, Claire Malley, Patricia Taylor, et al.
Allergy|June 30, 2025
The Evolution, Immunopathogenesis and Biomarkers of Type 2 Inflammation in Common Allergic DisordersYa-Dong Gao, Zi-Jun Wang, Ismail Ogulur, et al.
Journal of Drugs in Dermatology : JDD|December 4, 2024
International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual MeetingArianna J Zhang, Gretchen Ball, Melissa P Zundell, et al.
Allergy|December 18, 2025
Clinical and Molecular Effect of the Anti-IL-18 Antibody Aletekitug in Adults With Atopic DermatitisJoanne Ellis, Léa Fortunato, Hannah Wajdner, et al.
The Journal of Allergy and Clinical Immunology|January 7, 2024
Regulatory T-cell dysfunction and cutaneous exposure to Staphylococcus aureus underlie eczema in DOCK8 deficiencyHazel Wilkie, Mrinmoy Das, Tyler Pelovitz, et al.
The British Journal of Dermatology|September 9, 2024
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema CouncilCarter Haag, Andrew Alexis, Valeria Aoki, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Clinical and Translational Medicine|May 6, 2022
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trialAnne Weiss, Emilie Delavenne, Carina Matias, et al.
Pageof 39